Ardelyx (ARDX) Revenue Growth (5y) (2018 - 2026)
Ardelyx (ARDX) Revenue Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.37% |
| Dec 31, 2025 | 133.37% |
| Sep 30, 2025 | 4.62% |
| Jun 30, 2025 | 121.40% |
| Mar 31, 2025 | 127.62% |
| Dec 31, 2024 | 120.07% |
| Sep 30, 2024 | 100.75% |
| Jun 30, 2024 | 427.08% |
| Dec 31, 2023 | 232.15% |
| Sep 30, 2023 | 218.52% |
| Jun 30, 2023 | 275.29% |
| Mar 31, 2023 | 37.42% |
| Sep 30, 2020 | -33.97% |
| Jun 30, 2020 | -36.75% |
| Mar 31, 2020 | -27.08% |
| Dec 31, 2019 | -18.71% |
| Sep 30, 2019 | -16.89% |
| Jun 30, 2019 | -71.23% |
| Dec 31, 2018 | -60.18% |
| Sep 30, 2018 | -51.77% |